Fassan, Matteo
Università degli Studi di Padova,
Italy
2025 Rank: 35013
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1042 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 35013 | 35031 |
| Total Cites | 3379 | 3910 |
| H-index | 25 | 26 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 54 | 54 |
| Total Cites to Single+First Authored Papers | 63 | 73 |
| Number of Single+First+Last Authored Papers | 137 | 137 |
| Total Cites to Single+First+Last Authored Papers | 388 | 444 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3037 | 3348 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.17 |
| Self-Citation Percentage |
13.58%
|
|
Fassan, Matteo
Università degli Studi di Padova,
Italy
2024 Rank: 46297
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1489 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46297 | 32749 |
| Total Cites | 3307 | 3945 |
| H-index | 24 | 26 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 1 | 2 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 61 | 89 |
| Number of Single+First+Last Authored Papers | 131 | 131 |
| Total Cites to Single+First+Last Authored Papers | 349 | 437 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2920 | 3268 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.21 |
| Self-Citation Percentage |
16.17%
|
|
Fassan, Matteo
Università degli Studi di Padova,
Italy
2023 Rank: 42659
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1509 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42659 | 29651 |
| Total Cites | 2937 | 3463 |
| H-index | 20 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 3 | 7 |
| Number of Single+First Authored Papers | 52 | 52 |
| Total Cites to Single+First Authored Papers | 77 | 100 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 297 | 371 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2653 | 2975 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.16 |
| Self-Citation Percentage |
15.19%
|
|
Fassan, Matteo
Università degli Studi di Padova,
Italy
2022 Rank: 40330
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1524 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 40330 | 28762 |
| Total Cites | 2509 | 3007 |
| H-index | 20 | 21 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 6 | 9 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 76 | 107 |
| Number of Single+First+Last Authored Papers | 103 | 103 |
| Total Cites to Single+First+Last Authored Papers | 225 | 290 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2283 | 2572 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.17 |
| Self-Citation Percentage |
16.56%
|
|
Fassan, Matteo
Università degli Studi di Padova,
Italy
2021 Rank: 42939
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1558 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42939 | 33220 |
| Total Cites | 3329 | 3995 |
| H-index | 23 | 27 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 9 | 13 |
| Number of Single+First Authored Papers | 47 | 47 |
| Total Cites to Single+First Authored Papers | 96 | 131 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 274 | 344 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3005 | 3397 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.18 |
| Self-Citation Percentage |
16.67%
|
|
Fassan, Matteo
Università degli Studi di Padova,
Italy
2020 Rank: 79786
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2789 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79786 | 57867 |
| Total Cites | 1890 | 2243 |
| H-index | 19 | 21 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 4 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 77 | 105 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 138 | 180 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 1714 | 1896 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.18 |
| Self-Citation Percentage |
15.74%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.